Literature DB >> 26455573

Comparing an in vivo egg reduction test and in vitro egg hatching assay for different anthelmintics against Fasciola species, in cattle.

Waleed M Arafa1, Khalid M Shokeir2, Abdelrahman M Khateib2.   

Abstract

This study aimed to compare between the efficiency of in vivo fecal egg reduction test (FERT) and in vitro egg hatching assay (EHA) in evaluating of the anti-Fasciola activity of albendazole, triclabendazole, oxyclozanide and praziquantel. A field trial was carried out on fifty naturally Fasciola infected cattle that were divided equally into 5 groups (A-E). On day zero; groups A-D were drenched with albendazole, triclabendazole, oxyclozanide or praziquantel, respectively, while the remaining one, group E, was kept as untreated control. Fecal egg counts of the different groups were conducted weekly over a period of one month post-treatment. In vitro, commercial albendazole and oxyclozanide were diluted to 0.0002, 0.002, 0.02, 0.2 and 2.0 μg/ml, while commercial triclabendazole and praziquantel were diluted to concentrations of 25, 50, 75 and 100 μg/ml with dimethyl sulfoxide (DMSO). In vivo, at the 2nd week post-treatment, triclabendazole and oxyclozanide showed 100% fecal egg reduction (FER), and albendazole had a maximum of 73.7% reduction (P < 0.0001), however, praziquantel did not record any reduction of Fasciola egg counts. In vitro, triclabendazole treated Fasciola gigantica eggs showed early embryonic lysis with zero% hatching at the different concentrations (P < 0.01). In albendazole, the hatching varied according to the drug concentration. At the highest two concentrations; 0.2 and 2.0 μg/ml, the hatching percentages were 7.4 ± 1.6 and 5.6 ± 1.5 (P < 0.01) respectively. On the contrary, there were no significant differences in egg development and hatching percentage of oxyclozanide or praziquantel treated groups. In conclusion, the efficacy of triclabendazole and albendazole as fasciolicdes could be predicted by Egg Hatching Assay (EHA). Meanwhile fasciolicide activity of oxyclozanide could not be assessed with EHA. Based on in vivo and in vitro findings, paraziquantel did not show any fasciolicide effect.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Benzamidazole; Egg hatching assay; Fasciola gigantica; Fecal egg reduction test; Oxyclozanide; Praziquantel

Mesh:

Substances:

Year:  2015        PMID: 26455573     DOI: 10.1016/j.vetpar.2015.09.023

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  5 in total

1.  Field study on the determination of the effective dose of injectable fosfatriclaben prodrug in sheep naturally infected with Fasciola hepatica.

Authors:  Froylán Ibarra-Velarde; Tania Rojas-Campos; Yolanda Vera-Montenegro; Miguel Flores-Ramos; Rafael Castillo; Gerardo Leyva-Gómez
Journal:  Parasitol Res       Date:  2021-11-05       Impact factor: 2.289

2.  Comparative ovicidal activity of Moringa oleifera leaf extracts on Fasciola gigantica eggs.

Authors:  Ahmed G Hegazi; Kadria N Abdel Megeed; Soad E Hassan; M M Abdelaziz; Nagwa I Toaleb; Eman E El Shanawany; Dina Aboelsoued
Journal:  Vet World       Date:  2018-02-19

3.  Inhibitory Activities of Ethanolic Extracts of Two Macrofungi Against Eggs and Miracidia of Fasciola Spp.

Authors:  Somtochukwu C Nwofor; Olajumoke A Morenikeji; Adeoye-Isijola O Morenike; Oyetunde T Oyeyemi
Journal:  Open Life Sci       Date:  2019-01-04       Impact factor: 0.938

Review 4.  Plant-Based Natural Products for the Discovery and Development of Novel Anthelmintics against Nematodes.

Authors:  Maoxuan Liu; Sujogya Kumar Panda; Walter Luyten
Journal:  Biomolecules       Date:  2020-03-09

Review 5.  Drug resistance in liver flukes.

Authors:  I Fairweather; G P Brennan; R E B Hanna; M W Robinson; P J Skuce
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2020-01-10       Impact factor: 4.077

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.